Download video

Cynata Therapeutics (ASX:CYP): Things are looking up in 2023

300 views

Stocks Down Under

2 years ago

Cynata Therapeutics (ASX:CYP): Things are looking up in 2023

Cynata Therapeutics (ASX:CYP): Things are looking up in 2023

Cynata Therapeutics (ASX:CYP): Things are looking up in 2023
18:40
Cynata Therapeutics (ASX:CYP): Things are looking up in 2023
by Stocks Down Under
Cynata's Cymerus™ Technology
1:53
Cynata's Cymerus™ Technology
by Cynata Therapeutics
Cynata Therapeutics (ASX:CYP) is making steady progress: Interview with Dr. Kilian Kelly
21:41
Cynata Therapeutics (ASX:CYP) is making steady progress: Interview with Dr. Kilian Kelly
by Stocks Down Under
Cynata's Cymerus™ Technology (Japanese)
2:15
Cynata's Cymerus™ Technology (Japanese)
by Cynata Therapeutics
Cynata Therapeutics (ASX:CYP) CEO, Kilian Kelly
11:48
Cynata Therapeutics (ASX:CYP) CEO, Kilian Kelly
by Bell Potter
ASX:CYP - Cynata Therapeutics Managing Director Dr. Ross Macdonald on Bulls N' Bears 6PR Report
3:33
ASX:CYP - Cynata Therapeutics Managing Director Dr. Ross Macdonald on Bulls N' Bears 6PR Report
by Bulls N' Bears
Cynata Therapeutics opens first US site in Phase 2 CYP-001 trial
6:15
Cynata Therapeutics opens first US site in Phase 2 CYP-001 trial
by Proactive Investors
Cynata Therapeutics
15:04
Cynata Therapeutics
by Alliance for Regenerative Medicine
Gemcitabine\/nab-paclitaxel compared with 5-fluorouracil\/leucovorin\/liposomal irinotecan show sim...
11:46
Gemcitabine\/nab-paclitaxel compared with 5-fluorouracil\/leucovorin\/liposomal irinotecan show sim...
by ecancer
Translational research: Discover the key to scalable success
2:00
Translational research: Discover the key to scalable success
by Cytiva
CTX131 Could Change Solid Tumor Treatment—Here’s How It Works
7:52
CTX131 Could Change Solid Tumor Treatment—Here’s How It Works
by ShareTreck
Cynata Therapeutics
14:19
Cynata Therapeutics
by Alliance for Regenerative Medicine
Cynata Therapeutics
14:57
Cynata Therapeutics
by Alliance for Regenerative Medicine
JMM Ethica Interview with Cynata Therapeutics
9:14
JMM Ethica Interview with Cynata Therapeutics
by Cynata Therapeutics
From the helm: Cynata Therapeutics (ASX:CYP), Kilian Kelly, CEO
11:51
From the helm: Cynata Therapeutics (ASX:CYP), Kilian Kelly, CEO
by Bell Direct
CRISPR Therapeutics’ SyNTase Platform Explained | Can CTX460 Beat Beam Therapeutics in AATD?
9:03
CRISPR Therapeutics’ SyNTase Platform Explained | Can CTX460 Beat Beam Therapeutics in AATD?
by ShareTreck
Advanced Cancer Testing: Personalized Treatment Selection
9:14
Advanced Cancer Testing: Personalized Treatment Selection
by Patient Led Oncology
Cynata Therapeutics
15:08
Cynata Therapeutics
by Alliance for Regenerative Medicine
Cynata Therapeutics
18:06
Cynata Therapeutics
by Alliance for Regenerative Medicine
Cynata Therapeutics
14:50
Cynata Therapeutics
by Alliance for Regenerative Medicine
Cynata looking to revolutionise stem cell therapy
0:09
Cynata looking to revolutionise stem cell therapy
by Aziz Brain
Cynata Therapeutics
15:48
Cynata Therapeutics
by Alliance for Regenerative Medicine